L

Lord Vallance of Balham (Lab)

Speaking in the House of Lords on 6 February 2025

Debate

AstraZeneca

Contribution

I think it is undoubtedly a commercial decision. Having been head of R&D for a multinational pharmaceutical company, I know exactly how these decisions are made. It will have been a commercial decision as to where it needs to make the right investments for its vaccine manufacturing. I think the small change in the deal from the UK Government was probably a minor part in the overall decision-making.

More from Lord Vallance of Balham (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites